Patent 9249161 was granted and assigned to CONSTELLATION PHARMACEUTICALS INC on February, 2016 by the United States Patent and Trademark Office.
The present invention relates to compounds useful as inhibitors of bromodomain-containing proteins. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.